← All stocks

AbbVie

ABBV No buying or selling
CIK 0001551152 #14 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

25 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
GONZALEZ RICHARD A
Director
386,479
$96.62M
−13.5%
SALEKI-GERHARDT AZITA
EVP, CHIEF OPERATIONS OFFICER
197,794
$49.45M
+9.0%
Michael Robert A.
CHAIRMAN OF THE BOARD AND CEO
178,737
$44.68M
+81.2%
FREYMAN THOMAS C
Director
127,869
$31.97M
+1.8%
Stewart Jeffrey Ryan
EVP, CHIEF COMMERCIAL OFFICER
83,171
$20.79M
+36.5%
Donoghoe Nicholas
EVP, CHIEF BUS/STRAT OFFICER
74,430
$18.61M
+29.6%
Thakkar Roopal
EVP, R&D and CSO
52,376
$13.09M
+43.9%
TILTON GLENN F
Director
51,564
$12.89M
+2.4%
RAPP EDWARD J
Director
45,964
$11.49M
+5.3%
AUSTIN ROXANNE S
Director
39,576
$9.89M
+6.2%
Reents Scott T
EVP, CHIEF FINANCIAL OFFICER
38,777
$9.69M
+151.3%
Alpern Robert J
Director
35,646
$8.91M
+3.5%
WADDELL FREDERICK H
Director
30,076
$7.52M
+8.4%
BURNSIDE WILLIAM H.L.
Director
28,076
$7.02M
+9.0%
Hart Brett J
Director
20,590
$5.15M
+12.7%
MEYER MELODY B
Director
17,616
$4.40M
+15.2%
Roberts Rebecca B
Director
14,846
$3.71M
+18.5%
Crum Demetris D
EVP, CHIEF HR OFFICER
7,914
$1.98M
+12.3%
Buckbee Kevin K
SVP, CONTROLLER
7,797
$1.95M
+33.7%
RICHMOND TIMOTHY J.
EVP, CHIEF HR OFFICER
6,130
$1.53M
−55.7%
Siatis Perry C
EVP, GC AND SECRETARY
4,619
$1.15M
−55.6%
Quaggin Susan E
Director
3,643
$910.75K
+175.6%
Davis Jennifer L.
Director
3,643
$910.75K
+175.6%
Purdue David Ryan
SVP, Controller
2,654
$663.50K
−41.1%
FALK THOMAS J
Director
2,321
$580.25K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 9 Sep 2016